LPAR3 and Hutchinson-Gilford progeria syndrome: Furthermore, consistent with previous results, the lysosome inhibitor NH4Cl, but not the proteasome inhibitor MG132, rescued protein levels of LPA3, but not LPA1 or LPA2, in HGPS patient fibroblasts AG11 (Figure 4c).